selected publications
-
academic article
-
CDy14: a novel biofilm probe targeting exopolysaccharide Psl.
Chemical Communications.
54.
2018
Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin.
Oncotarget.
9.
2018
A broad range quorum sensing inhibitor working through sRNA inhibition.
Scientific Reports.
7.
2017
Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c‐di‐GMP effector BerB.
MicrobiologyOpen.
6.
2017
The Inoculation Method Could Impact the Outcome of Microbiological Experiments.
Applied and Environmental Microbiology.
84.
2017
The anti-cancerous drug doxorubicin decreases the c-di-GMP content in Pseudomonas aeruginosa but promotes biofilm formation.
Microbiology.
162.
2016
The dlt genes play a role in antimicrobial tolerance of Streptococcus mutans biofilms.
International Journal of Antimicrobial Agents.
48.
2016
C-di-GMP regulates Pseudomonas aeruginosa stress response to tellurite during both planktonic and biofilm modes of growth.
Scientific Reports.
5.
2015
The Cyclic AMP-Vfr Signaling Pathway in Pseudomonas aeruginosa Is Inhibited by Cyclic Di-GMP.
Journal of Bacteriology.
197.
2015
Antimicrobial and anti-biofilm effect of a novel BODIPY photosensitizer against Pseudomonas aeruginosa PAO1.
Biofouling.
30.
2014
-
chapter
-
hide from search
-
Duration of the chronic lung infection of CF patients harboring P. aeruginosa isolates producing both C4-HSL and 3-oxo-C12-HSL, either C4-HSL or 3-oxo-C12-HSL or none of the QS molecules and distribution of the rhamnolipid and elastase levels in CF P. aeruginosa isolates producing both, one or none of the QS molecules..
public-library-of-science.
2013
Bis-(3′-5′)-Cyclic Dimeric GMP Regulates Antimicrobial Peptide Resistance in Pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy.
2013
Clearance of Pseudomonas aeruginosa Foreign-Body Biofilm Infections through Reduction of the Cyclic Di-GMP Level in the Bacteria.
Infection and Immunity.
2013
-
patent